Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander N R Weber

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Cell Reports|September 2, 2025
Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunityRômulo Silva de Oliveira, Amy Shupe, Tim Krause, et al.
The Journal of Biological Chemistry|May 23, 2012
Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cellsJelena Knezević, Dinko Pavlinić, William A Rose, et al.
Frontiers in Immunology|June 14, 2021
NLRP3 Inflammasome Assembly in Neutrophils Is Supported by PAD4 and Promotes NETosis Under Sterile ConditionsPatrick Münzer, Roberto Negro, Shoichi Fukui, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
1-ethyl-3-(6-methylphenanthridine-8-il) urea modulates TLR3/9 activation and induces selective pro-inflammatory cytokine expression in vitroNatalija Knežević Teofilović, Mahjoub Bihi, Marijana Radić Stojković, et al.
Nature Communications|May 29, 2026
Non-decameric NLRP3 reveals a TGN/MTOC-distal pathway of inflammasome activationMaría Mateo-Tórtola, Inga V Hochheiser, Gaopeng Li, et al.
Scientific Reports|September 13, 2019
Putative link between Polo-like kinases (PLKs) and Toll-like receptor (TLR) signaling in transformed and primary human immune cellsSouhayla El Maadidi, Alexander N R Weber, Precious Motshwene, et al.
The Journal of Biological Chemistry|June 29, 2014
A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survivalHui Wang, Sinead M Flannery, Sabine Dickhöfer, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2025
Actionable heterogeneity of hepatocellular carcinoma therapy-induced senescencePujan Engels, Andras Szolek, Sebastian Hörner, et al.
Nature Communications|January 9, 2020
Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasisFranziska Herster, Zsofia Bittner, Nathan K Archer, et al.
Biomedicines|September 23, 2022
<i>TLR5</i> Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell LineJurica Baranašić, Maja Šutić, Calogerina Catalano, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Cell Reports|September 2, 2025
Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunityRômulo Silva de Oliveira, Amy Shupe, Tim Krause, et al.
The Journal of Biological Chemistry|May 23, 2012
Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cellsJelena Knezević, Dinko Pavlinić, William A Rose, et al.
Frontiers in Immunology|June 14, 2021
NLRP3 Inflammasome Assembly in Neutrophils Is Supported by PAD4 and Promotes NETosis Under Sterile ConditionsPatrick Münzer, Roberto Negro, Shoichi Fukui, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
1-ethyl-3-(6-methylphenanthridine-8-il) urea modulates TLR3/9 activation and induces selective pro-inflammatory cytokine expression in vitroNatalija Knežević Teofilović, Mahjoub Bihi, Marijana Radić Stojković, et al.
Nature Communications|May 29, 2026
Non-decameric NLRP3 reveals a TGN/MTOC-distal pathway of inflammasome activationMaría Mateo-Tórtola, Inga V Hochheiser, Gaopeng Li, et al.
Scientific Reports|September 13, 2019
Putative link between Polo-like kinases (PLKs) and Toll-like receptor (TLR) signaling in transformed and primary human immune cellsSouhayla El Maadidi, Alexander N R Weber, Precious Motshwene, et al.
The Journal of Biological Chemistry|June 29, 2014
A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survivalHui Wang, Sinead M Flannery, Sabine Dickhöfer, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2025
Actionable heterogeneity of hepatocellular carcinoma therapy-induced senescencePujan Engels, Andras Szolek, Sebastian Hörner, et al.
Nature Communications|January 9, 2020
Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasisFranziska Herster, Zsofia Bittner, Nathan K Archer, et al.
Biomedicines|September 23, 2022
<i>TLR5</i> Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell LineJurica Baranašić, Maja Šutić, Calogerina Catalano, et al.
Pageof 9